Are you taking lamotrigine?

Lamotrigine: Logem is the new funded brand

The funded brand of lamotrigine, a medicine used to treat epilepsy and some mental health conditions such as bipolar disorder, is changing from Lamictal, Arrow-Lamotrigine and Logem to Logem only. Although your tablets may look different, you are still receiving the same medicine.

From 1 May 2019 to 1 October 2019

  • People will have 5 months to change to the Logem brand of lamotrigine.

From 1 October 2019:

  • Logem will be the only funded brand of lamotrigine.
  • Lamotrigine will be able to be dispensed all at once, as a 3-month supply. If you want to stay with smaller quantities, then talk to your doctor or pharmacist.
  • Paediatric strengths are not changing: there are no changes to the listings of lamotrigine 2 mg (Lamictal) and 5 mg (Lamictal and Arrow-Lamotrigine) dispersible tablets.

If you have any questions about your medicines, talk to your doctor or pharmacist. If you want to keep using your current brand of lamotrigine, see Exceptional circumstances below.

Logem works the same as other brands

Logem has the same active ingredient as the other brands and is delivered to the body in the same way. This means your new brand of medicine works the same as your old brand. You shouldn't notice any difference in how it affects you.

Research into brand changes – how do you feel about changing brands?

Pharmac will often make decisions that mean people need to change the brand of their medicines. The University of Auckland is exploring this and want to hear from people to share their experiences of changing lamotrigine brands. If you're interested in sharing your experiences and taking part in the research, click here: Lamotrigine Brand Switch Survey All responses will be confidential. Participation in this research is voluntary.

Reimbursement of waived GP co-payment fees

If during the switch to Logem, you return to your GP with concerns following the change and need additional support to make a successful change, the cost you pay for your GP visit (known as a co-payment fee) may be waived and Pharmac will reimburse the GP clinic. Read more

Exceptional circumstances

If you think the new brand is not working, talk to your healthcare professional. Pharmac has a process for considering funding in exceptional circumstances for individual patients. Healthcare professionals can apply for funding for individuals using an exceptional circumstances form. Read more

Learn more

Your brand of lamotrigine is changing Pharmac
Lamotrigine: Logem is the new funded brand Pharmac
Decision to move to one funded brand of lamotrigine (Logem) Pharmac